If GI symptoms worsen during a taper step-down rather than improve, that is unusual and warrants clinical re-evaluation for an alternate cause
We're also tracking fat loss specifically not just the number on the scale because losing too much muscle while losing weight is not a win
doi:10.1111/dom.12924 MacLean PS, Wing RR, Davidson T, Epstein L, Goodpaster B, Hall KD, Levin BE, Perri MG, Rolls BJ, Rosenbaum M, Rothman AJ, Ryan D
For example, older adults with sarcopenia may be at the highest risk, as a further reduction in lean mass could jeopardize overall health and mobility
Impure peptide preparations can introduce experimental confounders, as degradation products or synthesis byproducts may have their own biological activities or interfere with receptor binding assays